EGFR and non-small cell lung carcinoma: The aim of this study is to establish a noninvasive predictive model of EGFR mutation based on clinical, imaging, and radiomic features, which can provide a basis for targeted therapy with patients who cannot be pathologically diagnosed with NSCLC and are unable to undergo EGFR gene mutation detection for various reasons.